# Chromosome 1 variants associated with decreased HIV set-point viral load correlate with PRKAB2 expression changes

**Authors:** Riley H. Tough, Paul J. McLaren

PMC · DOI: 10.3389/fgene.2025.1551171 · Frontiers in Genetics · 2025-03-06

## TL;DR

This study explores how genetic variations on chromosome 1 affect HIV viral load by influencing PRKAB2 and CHD1L gene expression in immune cells.

## Contribution

The study identifies PRKAB2 as a gene influenced by HIV set-point viral load-associated variants and links it to immune signaling pathways.

## Key findings

- Genetic variants on chromosome 1 correlate with PRKAB2 expression changes in whole blood and monocytes.
- PRKAB2 loss-of-function may influence CHD1L expression and immune signaling pathways related to HIV.
- These findings suggest host genetic factors impact HIV pathogenesis through PRKAB2 and CHD1L interactions.

## Abstract

A previous study investigated a genomic region on chromosome 1 associated with reduced human immunodeficiency virus type 1 (HIV) set-point viral load, implicating CHD1L as a novel HIV inhibitory factor. However, given that regulatory variants can influence expression of multiple nearby genes, further work is necessary to determine the impact of genetic variants on other genes in the region. This study evaluates the potential for genetic regulation of PRKAB2, a gene located upstream of CHD1L and encoding the β2 regulatory subunit of the AMPK complex, and for downstream impacts on HIV pathogenesis. Using genotype and gene expression data from the Gene Expression Omnibus repository and Genotype-Tissue Expression database, we observed cell-type-specific correlations between CHD1L and PRKAB2 expression, with a strong positive association in whole blood and negative correlation in monocytes. Notably, we found that individuals with HIV set-point viral load associated variants exhibited significantly reduced PRKAB2 expression in imputed whole blood models and ex vivo monocytes. Functional analyses using PRKAB2
−/− induced pluripotent stem cells suggest that PRKAB2 loss-of-function may influence CHD1L expression, and genes regulating cytokine activity, growth factor signaling, and pluripotency pathways associated with HIV infection. These results suggest that gene expression changes driven by HIV set-point viral load associated variants in the chromosome 1 impact multiple genes and, by influencing expression of PRKAB2, may result in altered expression of critical immune signaling processes. These findings advance our understanding of the contribution of host genetics on HIV pathogenesis and identifies new targets for ex vivo functional studies.

## Linked entities

- **Genes:** CHD1L (chromodomain helicase DNA binding protein 1 like) [NCBI Gene 9557], PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2) [NCBI Gene 5565]

## Full-text entities

- **Genes:** PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2) [NCBI Gene 5565], CHD1L (chromodomain helicase DNA binding protein 1 like) [NCBI Gene 9557] {aka ALC1, CHDL}
- **Diseases:** HIV infection (MESH:D015658)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11922826/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11922826/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC11922826/full.md

---
Source: https://tomesphere.com/paper/PMC11922826